Editor's Notes: * Why this sector matters right now: The Agriculture sector is starting to look like a genuine early-recovery setup. Protein demand is firmer than headlines suggest, inventories are tight, utilization is improving, and input costs have stabilized. The missing piece has been policy clarity, not fundamentals.
Editor's Notes: * The U.S. tape still feels “up,” but it’s a very specific kind of up. The rally on de-escalating trade headlines is real, but the market’s tolerance for surprises looks low. A slightly-hot PCE print and all the talk about “AI bubble”
Editor's Notes * The headline changed (again), but the signal didn’t. Even if the Europe tariff threat tied to Greenland gets toned down or paused, the bigger takeaway is the policy unpredictability premium that’s creeping into markets. What caught my eye was the flow-driven response from
Editor’s Notes * Why now: Parts of the agriculture sector look close to a cyclical low after a prolonged period of weak commodity prices and pressured earnings. At the same time, underlying demand for food and ag-related assets has not gone away. For patient investors, this feels like a
Editor’s Notes * Today has that classic risk-off tape with an extra layer of “this could gap again”. The headline is Trump’s tariff threat on Europe tied to Greenland, but the real market signal was capital flow behavior, not the soundbites. A Danish pension fund walking away from
Investment
Editor’s Notes * Japan is back in the driver’s seat, but this is no longer a passive trade. The so-called Takaichi Trade is powering the Nikkei through exporters, defense, and AI-linked industrials, helped by yen weakness and fiscal expectations. That said, with daily moves stretching and policy
Editor’s Notes: * The consumer is holding up better than feared. What stood out this week was the consistency of demand signals across regions. MUJI’s Asia-led growth speaks to real spending power, not just promotions, and J.B. Hunt’s customers talking about a potential $100–160bn spring
Editor's Notes: * This is the Part II for the life science tools & services sector survey, mainly to assess "second-order implications" based on fundamental outlook vs. what's likely been priced in based on narratives. This piece provides a different perspective to double check
Editor's Notes: * We have run two AI-generated sector analyses this weekend on Life Science Tools & Services, as a follow up to our profile on Revvity earlier this week. * This industry has historically been a traditional cyclical industry. However, a few tailwinds may make this sector interesting
Editor's Notes: * New structural themes for 2026 are largely confirmed by the past few days' trading - governance / economic reform continues driving JP bull, HK markets ready for rerating but waiting for more substantial recovery catalysts, SaaS names are hated while Trump policy / AI supply beneficiaries dominate US.
Investment
Editor's Notes: * We have seen consecutive days of stock price declines for SaaS names. This is part of a rotation. The deeper reason is likely a consensus forming around the generational profile shift from SaaS to AI apps. My thesis is that if SaaS players adopts AI aggressively,
Investment
Editor's Notes: * Rotating Eastward: US stocks are expensive and subject to increasing policy uncertainties; naturally, investors are looking elsewhere. Asia markets already had a very strong 2025, and I expect the China consumption recovery play (e.g. Anta, Nongfu), China AI play, Asia healthcare innovation cycle, Japan revitalization,